Clinical trial

A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.

NCT06075615

StatusWITHDRAWN

Study typeOBSERVATIONAL

Start date2024-09-30

PhaseN/A

Study timeline

Study start (estimated)2024-09-30Date precision: day

Registry last updated2025-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

dacomitnibDRUG

Sponsors & collaborators

Pfizerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06075615 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.